JP2019520365A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019520365A5 JP2019520365A5 JP2018568285A JP2018568285A JP2019520365A5 JP 2019520365 A5 JP2019520365 A5 JP 2019520365A5 JP 2018568285 A JP2018568285 A JP 2018568285A JP 2018568285 A JP2018568285 A JP 2018568285A JP 2019520365 A5 JP2019520365 A5 JP 2019520365A5
- Authority
- JP
- Japan
- Prior art keywords
- stem cells
- pharmaceutical composition
- exosomes
- thrombin
- derived
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20160083703 | 2016-07-01 | ||
| KR10-2016-0083703 | 2016-07-01 | ||
| KR1020170080366A KR101860266B1 (ko) | 2016-07-01 | 2017-06-26 | 트롬빈 처리 줄기세포에서 유래된 엑소좀을 포함하는 피부상처 치료용 조성물 |
| KR10-2017-0080366 | 2017-06-26 | ||
| PCT/KR2017/006776 WO2018004237A1 (ko) | 2016-07-01 | 2017-06-27 | 트롬빈 처리 줄기세포에서 유래된 엑소좀을 포함하는 피부상처 치료용 조성물 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019520365A JP2019520365A (ja) | 2019-07-18 |
| JP2019520365A5 true JP2019520365A5 (cg-RX-API-DMAC10.html) | 2020-04-09 |
| JP6826135B2 JP6826135B2 (ja) | 2021-02-03 |
Family
ID=60998515
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018568285A Active JP6826135B2 (ja) | 2016-07-01 | 2017-06-27 | トロンビン処理幹細胞に由来するエクソソームを含む皮膚傷治療用組成物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US12239695B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP3479831B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP6826135B2 (cg-RX-API-DMAC10.html) |
| KR (1) | KR101860266B1 (cg-RX-API-DMAC10.html) |
| CN (1) | CN109641013B (cg-RX-API-DMAC10.html) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101973284B1 (ko) | 2017-01-16 | 2019-04-29 | 사회복지법인 삼성생명공익재단 | 신생아 ｈｉｅ 치료용 조성물 |
| KR102278102B1 (ko) | 2018-07-27 | 2021-07-15 | 주식회사 엑소스템텍 | 엑소좀을 유효성분으로 포함하는 급성 간질환의 예방 또는 치료용 조성물 |
| EP3831397A4 (en) | 2018-07-27 | 2022-05-18 | Exostemtech Co., Ltd. | COMPOSITION WITH EXOSOME AS AN AGENTS FOR PREVENTION OR TREATMENT OF ACUTE LIVER FAILURE |
| KR102323056B1 (ko) * | 2019-05-02 | 2021-11-09 | 에스씨엠생명과학 주식회사 | hPL 함유 배지에서 배양된 중간엽 줄기세포의 배양액을 포함하는 화장료 조성물 |
| KR102159394B1 (ko) * | 2019-10-04 | 2020-09-24 | (주)에스디생명공학 | 바다제비집에서 유래된 엑소좀을 유효성분으로 포함하는 피부 상태 개선용 조성물 |
| US12491212B2 (en) | 2019-11-12 | 2025-12-09 | Brexogen Inc. | Composition for preventing or treating renal diseases, comprising exosomes derived from precursor cells of induced pluripotent stem cell-derived mesenchymal stem cells |
| JP2021116228A (ja) * | 2020-01-22 | 2021-08-10 | 医薬資源研究所株式会社 | 抗酸化ストレス剤、化粧品、および医薬品 |
| US12077780B2 (en) | 2020-02-14 | 2024-09-03 | Allergan Sales, Llc | Conditioned medium from cells cultured under hypoxic conditions and uses thereof |
| KR20210127510A (ko) * | 2020-04-14 | 2021-10-22 | 사회복지법인 삼성생명공익재단 | 트롬빈 처리 줄기세포에서 유래된 엑소좀을 포함하는 당뇨병성 피부질환 예방 또는 치료용 조성물 |
| CN111888379A (zh) * | 2020-08-17 | 2020-11-06 | 济宁医学院附属医院 | 干细胞来源的微囊泡在制备修复瘢痕的制剂中的应用 |
| WO2022114730A2 (ko) * | 2020-11-26 | 2022-06-02 | 사회복지법인 삼성생명공익재단 | 트롬빈 처리 줄기세포에서 유래된 엑소좀을 포함하는 감염성 질환 치료용 조성물 |
| EP4364728A4 (en) * | 2021-06-30 | 2025-07-02 | Primoris Therapeutics Co Ltd | PHARMACEUTICAL COMPOSITION CONTAINING NATURAL OR ARTIFICIAL CELL-DERIVED NANOVESICLES LOADED WITH AN ANTISENSE OLIGONUCLEOTIDE-BASED DRUG |
| CN114904043B (zh) * | 2022-04-28 | 2023-07-21 | 深圳市儿童医院 | 复合水凝胶及其制备方法和应用 |
| KR102633660B1 (ko) * | 2022-05-04 | 2024-02-05 | (주)에스엔이바이오 | 효능이 증진된 줄기세포 유래 세포외소포를 포함하는 상처 치료용 조성물 |
| JP2025539861A (ja) * | 2022-11-25 | 2025-12-09 | エルピス・セル・セラピューティクス | ｖＭＳＣのセクレトームおよびその用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5911874B2 (ja) * | 2010-10-18 | 2016-04-27 | エージェンシー フォー サイエンス，テクノロジー アンド リサーチ | 発毛を促進又は増強するためのエキソソームの使用 |
| EP2850178A4 (en) | 2012-05-18 | 2015-10-28 | Agency Science Tech & Res | MESENCHYMAL NAIL STAMMING CELL EXOSOME |
| KR20140066456A (ko) | 2012-11-23 | 2014-06-02 | 호서대학교 산학협력단 | 피부각질세포 유래 엑소좀, 엑소좀을 포함하는 분획물의 피부재생용 화장품 조성물 및 이의 용도 |
| GB201317889D0 (en) | 2013-10-09 | 2013-11-20 | Reneuron Ltd | Product and use |
| US10167448B2 (en) * | 2013-12-12 | 2019-01-01 | Samsung Life Public Welfare Foundation | Pharmaceutical composition for treating cerebrovascular diseases, containing stem cell-derived exosome as active ingredient |
| WO2015142061A1 (ko) * | 2014-03-18 | 2015-09-24 | 사회복지법인 삼성생명공익재단 | 줄기세포 유래 엑소좀을 유효성분으로 포함하는 뇌 염증성 질환의 치료용 조성물 |
| CN105477016A (zh) * | 2015-11-13 | 2016-04-13 | 中国人民解放军第二军医大学 | 人间充质干细胞来源的外泌体在抗组织纤维化及瘢痕形成中的应用 |
-
2017
- 2017-06-26 KR KR1020170080366A patent/KR101860266B1/ko active Active
- 2017-06-27 EP EP17820513.4A patent/EP3479831B1/en active Active
- 2017-06-27 US US16/314,725 patent/US12239695B2/en active Active
- 2017-06-27 CN CN201780047575.0A patent/CN109641013B/zh active Active
- 2017-06-27 JP JP2018568285A patent/JP6826135B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Xie et al. | What is the impact of human umbilical cord mesenchymal stem cell transplantation on clinical treatment? | |
| da Silva et al. | Stem cell-containing hyaluronic acid-based spongy hydrogels for integrated diabetic wound healing | |
| Barakat et al. | Limited treatment options for diabetic wounds: barriers to clinical translation despite therapeutic success in murine models | |
| US10993965B2 (en) | Lyophilized platelet lysates | |
| US12239695B2 (en) | Composition comprising thrombin-treated stem cell-derived exosome for treating skin wound | |
| CN107106613B (zh) | 用于成脂分化诱导、脂肪组织再生、皮肤美白或改善皱纹的包含干细胞来源外泌体的组合物 | |
| Zhan et al. | Macrophage-derived microvesicles promote proliferation and migration of Schwann cell on peripheral nerve repair | |
| Sun et al. | Sequential paracrine mechanisms are necessary for the therapeutic benefits of stem cell therapy | |
| TWI857807B (zh) | 含有粒線體之組合物及其用於作為皮膚纖維母細胞活性促進劑之用途 | |
| Da Silva et al. | The paradigm of stem cell secretome in tissue repair and regeneration: Present and future perspectives | |
| Wang et al. | Diverse-origin exosomes therapeutic strategies for diabetic wound healing | |
| RU2015137965A (ru) | Сывороточная фракция обогащенного тромбоцитами фибрина | |
| Nie et al. | Non-stem cell-derived exosomes: a novel therapeutics for neurotrauma | |
| Wang et al. | Mesenchymal stem cell-derived exosomes hold promise in the treatment of diabetic foot ulcers | |
| JP2023105066A (ja) | 組織治癒剤 | |
| EP3656850A1 (en) | Mesenchymal-stem-cell induction agent | |
| JP2016202098A (ja) | マンネンタケ抽出物を用いた幹細胞の未分化状態維持剤及び増殖促進剤 | |
| Mörschbächer et al. | Treatment of dilated cardiomyopathy in rabbits with mesenchymal stem cell transplantation and platelet-rich plasma | |
| Mester et al. | Stem cell therapy in wound healing | |
| DK2431046T3 (en) | Application of olive leaf extract in a pharmaceutical composition for inducing angiogenesis and vasculogenesis | |
| JP5251873B2 (ja) | 脂肪組織細胞画分の照射後組織再生への使用 | |
| Trivisonno et al. | Adipose tissue: from energy reservoir to a source of cells for epithelial tissue engineering | |
| Aidarova et al. | Applications of cord blood cells in neurology | |
| Palma et al. | Therapeutic potential of adipose-derived stem cells for noncommunicable diseases | |
| KR102633660B1 (ko) | 효능이 증진된 줄기세포 유래 세포외소포를 포함하는 상처 치료용 조성물 |